| __timestamp | Incyte Corporation | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 511495000 | 2819557000 |
| Thursday, January 1, 2015 | 753751000 | 4103728000 |
| Friday, January 1, 2016 | 1105719000 | 4860427000 |
| Sunday, January 1, 2017 | 1536216000 | 5872227000 |
| Monday, January 1, 2018 | 1881883000 | 6710800000 |
| Tuesday, January 1, 2019 | 2158759000 | 7863400000 |
| Wednesday, January 1, 2020 | 2666702000 | 8497100000 |
| Friday, January 1, 2021 | 2986267000 | 16071700000 |
| Saturday, January 1, 2022 | 3394635000 | 12172900000 |
| Sunday, January 1, 2023 | 3695649000 | 13117200000 |
| Monday, January 1, 2024 | 4241217000 | 14202000000 |
Unleashing the power of data
In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outperformed Incyte Corporation in terms of revenue generation. Starting in 2014, Regeneron's revenue was approximately five times that of Incyte's. By 2023, Regeneron's revenue had surged to nearly 13 billion, maintaining a lead of over 3.5 times Incyte's revenue.
This data highlights the dynamic nature of the biotech industry, where innovation and strategic investments drive substantial financial growth.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: Examining Key Revenue Metrics
AbbVie Inc. vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Gilead Sciences, Inc. or Regeneron Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited
Who Generates More Revenue? Regeneron Pharmaceuticals, Inc. or Travere Therapeutics, Inc.
Revenue Showdown: GSK plc vs Incyte Corporation
Incyte Corporation or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Incyte Corporation vs Galapagos NV: Annual Revenue Growth Compared
Incyte Corporation and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis